{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:38:41Z","timestamp":1778657921617,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/nrmicro3217","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T11:22:25Z","timestamp":1392031345000},"page":"223-229","source":"Crossref","is-referenced-by-count":94,"title":["Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance"],"prefix":"10.1038","volume":"12","author":[{"given":"Namraj","family":"Goire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica M.","family":"Lahra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Guy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Regan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo P.","family":"Sloots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Whiley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,10]]},"reference":[{"key":"BFnrmicro3217_CR1","first-page":"627","volume-title":"Sexually Transmitted Diseases 4th edn","author":"KK Holmes","year":"2008","unstructured":"Holmes, K. K. et al. in Sexually Transmitted Diseases 4th edn 627\u2013645 (McGraw Hill, 2008)."},{"key":"BFnrmicro3217_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.7326\/0003-4819-148-8-200804150-00005","volume":"148","author":"KA Workowski","year":"2008","unstructured":"Workowski, K. A., Berman, S. M. & Douglas, J. M. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann. Intern. Med. 148, 606\u2013613 (2008).","journal-title":"Ann. Intern. Med."},{"key":"BFnrmicro3217_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/14656560902731993","volume":"10","author":"PM Barry","year":"2009","unstructured":"Barry, P. M. & Klausner, J. D. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert. Opin. Pharmacother. 10, 555\u2013577 (2009).","journal-title":"Expert. Opin. Pharmacother."},{"key":"BFnrmicro3217_CR4","doi-asserted-by":"publisher","first-page":"i29","DOI":"10.1093\/jac\/dkp255","volume":"64","author":"DM Livermore","year":"2009","unstructured":"Livermore, D. M. Has the era of untreatable infections arrived? J. Antimicrob. Chemother. 64, i29\u2013i36 (2009).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrmicro3217_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/sti.2010.042648","volume":"86","author":"DA Lewis","year":"2010","unstructured":"Lewis, D. A. The Gonococcus fights back: is this time a knock out? Sex. Transm. Infect. 86, 415\u2013421 (2010).","journal-title":"Sex. Transm. Infect."},{"key":"BFnrmicro3217_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11908-011-0169-9","volume":"13","author":"R Kirkcaldy","year":"2011","unstructured":"Kirkcaldy, R., Ballard, R. & Dowell, D. Gonococcal resistance: are cephalosporins next? Curr. Infect. Dis. Rep. 13, 196\u2013204 (2011).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"BFnrmicro3217_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/eri.09.63","volume":"7","author":"JW Tapsall","year":"2009","unstructured":"Tapsall, J. W. et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev. Anti Infect. Ther. 7, 821\u2013834 (2009).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"BFnrmicro3217_CR8","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi, M. et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob. Agents Chemother. 55, 3538\u20133545 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro3217_CR9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Ohnishi","year":"2012","unstructured":"Ohnishi, M. et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56, 1273\u20131280 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro3217_CR10","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1128\/AAC.00245-10","volume":"54","author":"M Ohnishi","year":"2010","unstructured":"Ohnishi, M., Ono, E., Shimuta, K., Watanabe, H. & Okamura, N. Identification of TEM-135 \u03b2-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan. Antimicrob. Agents Chemother. 54, 3021\u20133023 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro3217_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1128\/AAC.05665-11","volume":"56","author":"S-I Nakayama","year":"2012","unstructured":"Nakayama, S.-I. et al. Molecular analyses of TEM genes and their corresponding penicillinase-producing Neisseria gonorrhoeae isolates in Bangkok, Thailand. Antimicrob. Agents Chemother. 56, 916\u2013920 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro3217_CR12","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1128\/AAC.00036-12","volume":"56","author":"D Golparian","year":"2012","unstructured":"Golparian, D. et al. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? Antimicrob. Agents Chemother. 56, 2739\u20132742 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro3217_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/jac\/dkh272","volume":"54","author":"DM Livermore","year":"2004","unstructured":"Livermore, D. M. et al. Activity of ertapenem against Neisseria gonorrhoeae. J. Antimicrob. Chemother. 54, 280\u2013281 (2004).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrmicro3217_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/sextrans-2011-050362","volume":"88","author":"JDC Ross","year":"2012","unstructured":"Ross, J. D. C. & Lewis, D. A. Cephalosporin resistant Neisseria gonorrhoeae: time to consider gentamicin? Sex. Transm. Infec. 88, 6\u20138 (2012).","journal-title":"Sex. Transm. Infec."},{"key":"BFnrmicro3217_CR15","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1136\/bmj.289.6451.1032","volume":"289","author":"CS Easmon","year":"1984","unstructured":"Easmon, C. S. et al. Spectinomycin as initial treatment for gonorrhoea. BMJ 289, 1032\u20131034 (1984).","journal-title":"BMJ"},{"key":"BFnrmicro3217_CR16","first-page":"A14","volume":"89","author":"B Kirkcaldy","year":"2013","unstructured":"Kirkcaldy, B. Treatment of gonorrhea in an era of emerging cephalosporin resistance and results of a randomized trial of new potential treatment options. Sex. Trans. Infect. 89, A14 (2013).","journal-title":"Sex. Trans. Infect."},{"key":"BFnrmicro3217_CR17","unstructured":"Centers for Disease, Control and Prevention. Ceftriaxone-resistant Neisseria gonorrhoeae public health response plan [online] , (2012)."},{"key":"BFnrmicro3217_CR18","unstructured":"Department of Reproductive Health and Research, World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae [online] , (2012)."},{"key":"BFnrmicro3217_CR19","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR 61, 590\u2013594 (2012).","DOI":"10.1016\/j.annemergmed.2012.10.014"},{"key":"BFnrmicro3217_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","volume":"22","author":"C Bignell","year":"2011","unstructured":"Bignell, C. & Fitzgerald, M. UK national guideline for the management of gonorrhoea in adults, 2011. Int. J. STD AIDS. 22, 541\u2013547 (2011).","journal-title":"Int. J. STD AIDS."},{"key":"BFnrmicro3217_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell, C. et al. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int. J. STD AIDS 24, 85\u201392 (2013).","journal-title":"Int. J. STD AIDS"},{"key":"BFnrmicro3217_CR22","volume-title":"Neisseria gonorrhoeae","author":"JW Tapsall","year":"2001","unstructured":"Tapsall, J. W. Antibiotic Resistance in Neisseria gonorrhoeae (WHO, 2001)."},{"key":"BFnrmicro3217_CR23","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/AAC.00304-09","volume":"53","author":"S Zhao","year":"2009","unstructured":"Zhao, S. et al. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 53, 3744\u20133751 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro3217_CR24","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","volume":"46","author":"S Ameyama","year":"2002","unstructured":"Ameyama, S. et al. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob. Agents Chemother. 46, 3744\u20133749 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro3217_CR25","doi-asserted-by":"publisher","first-page":"8062","DOI":"10.1021\/bi101167x","volume":"49","author":"J Tomberg","year":"2010","unstructured":"Tomberg, J., Unemo, M., Davies, C. & Nicholas, R. A. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry 49, 8062\u20138070 (2010).","journal-title":"Biochemistry"},{"key":"BFnrmicro3217_CR26","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1128\/AAC.00093-13","volume":"57","author":"J Tomberg","year":"2013","unstructured":"Tomberg, J. et al. Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041. Antimicrob. Agents Chemother. 57, 3029\u20133036 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro3217_CR27","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","volume":"7","author":"M Unemo","year":"2012","unstructured":"Unemo, M. & Nicholas, R. A. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 7, 1401\u20131422 (2012).","journal-title":"Future Microbiol."},{"key":"BFnrmicro3217_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s101560170034","volume":"7","author":"S Akasaka","year":"2001","unstructured":"Akasaka, S. et al. Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce \u03b2-lactamase. J. Infect. Chemother. 7, 49\u201350 (2001).","journal-title":"J. Infect. Chemother."},{"key":"BFnrmicro3217_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijantimicag.2005.08.021","volume":"27","author":"M Tanaka","year":"2006","unstructured":"Tanaka, M. et al. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int. J. Antimicrob. Agents 27, 20\u201326 (2006).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFnrmicro3217_CR30","first-page":"19330","volume":"17","author":"HJ de Vries","year":"2009","unstructured":"de Vries, H. J., van der Helm, J. J., Schim van der Loeff, M. F. & van Dam, A. P. Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands. Euro. Surveill. 17, 19330 (2009).","journal-title":"Euro. Surveill."},{"key":"BFnrmicro3217_CR31","unstructured":"Australian Gonococcal Surveillance Programme. Annual report of Australian Gonococcal Surveillance Programme 2008. Commun. Dis. Intell. 34, 89\u201395 (2009)."},{"key":"BFnrmicro3217_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/sti.2010.044164","volume":"86","author":"MJ Cole","year":"2010","unstructured":"Cole, M. J. et al. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex. Transm. Infect. 86, 427\u2013432 (2010).","journal-title":"Sex. Transm. Infect."},{"key":"BFnrmicro3217_CR33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/sti.2010.045377","volume":"86","author":"D Golparian","year":"2010","unstructured":"Golparian, D., Hellmark, B., Fredlund, H. & Unemo, M. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex. Transm. Infect. 86, 454\u2013460 (2010).","journal-title":"Sex. Transm. Infect."},{"key":"BFnrmicro3217_CR34","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/OLQ.0b013e31822c664f","volume":"38","author":"I Martin","year":"2011","unstructured":"Martin, I. et al. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000\u20132009. Sex. Transm. Dis. 38, 892\u2013898 (2011).","journal-title":"Sex. Transm. Dis."},{"key":"BFnrmicro3217_CR35","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1469-0691.2011.03619.x","volume":"18","author":"A Carannante","year":"2012","unstructured":"Carannante, A. et al. Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010. Clin. Microbiol. Infect. 18, 558\u2013564 (2012).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFnrmicro3217_CR36","unstructured":"US Centers for Disease Control and Prevention. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates \u2014 United States, 2000\u20132010. MMWR 60, 873\u2013877 (2011)."},{"key":"BFnrmicro3217_CR37","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1093\/jac\/dkr332","volume":"66","author":"SA Chisholm","year":"2011","unstructured":"Chisholm, S. A. et al. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales. J. Antimicrob. Chemother. 66, 2509\u20132512 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrmicro3217_CR38","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/jac\/dkr052","volume":"66","author":"DM Whiley","year":"2011","unstructured":"Whiley, D. M. et al. Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is spread internationally by genetically distinct gonococcal populations. J. Antimicrob. Chemother. 66, 1186\u20131187 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrmicro3217_CR39","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","volume":"67","author":"J C\u00e1mara","year":"2012","unstructured":"C\u00e1mara, J. et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J. Antimicrob. Chemother. 67, 1858\u20131860 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrmicro3217_CR40","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1128\/JCM.05341-11","volume":"49","author":"M Bissessor","year":"2011","unstructured":"Bissessor, M. et al. Differing Neisseria gonorrhoeae bacterial loads in the pharynx and rectum in men who have sex with men: implications for gonococcal detection, transmission, and control. J. Clin. Microbiol. 49, 4304\u20134306 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrmicro3217_CR41","unstructured":"Department of Reproductive Health and Research, World Health Organization. Strategies and laboratory methods for strengthening surveillance of sexually transmitted infection 2012. (WHO, 2012)."},{"key":"BFnrmicro3217_CR42","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1086\/383047","volume":"189","author":"IMC Martin","year":"2004","unstructured":"Martin, I. M. C. et al. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J. Infect. Dis. 189, 1497\u20131505 (2004).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro3217_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/CMR.00040-10","volume":"24","author":"M Unemo","year":"2011","unstructured":"Unemo, M. & Dillon, J. A. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin. Microbiol. Rev. 24, 447\u2013458 (2011).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFnrmicro3217_CR44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/sti.2008.029694","volume":"84","author":"HM Palmer","year":"2008","unstructured":"Palmer, H. M., Young, H., Graham, C. & Dave, J. Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex. Transm. Infect. 84, 280\u2013284 (2008).","journal-title":"Sex. Transm. Infect."},{"key":"BFnrmicro3217_CR45","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1089\/mdr.2011.0229","volume":"18","author":"S Buono","year":"2012","unstructured":"Buono, S. et al. Using the Neisseria gonorrhoeae multi-antigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California. Microb. Drug Resist. 18, 510\u2013517 (2012).","journal-title":"Microb. Drug Resist."},{"key":"BFnrmicro3217_CR46","doi-asserted-by":"crossref","first-page":"20358","DOI":"10.2807\/ese.18.03.20358-en","volume":"18","author":"SA Chisholm","year":"2013","unstructured":"Chisholm, S. A. et al. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill. 18, 20358 (2013).","journal-title":"Euro Surveill."},{"key":"BFnrmicro3217_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/sti.2009.037689","volume":"1","author":"DM Whiley","year":"2010","unstructured":"Whiley, D. M. et al. Neisseria gonorrhoeae multi-antigen sequence typing using non-cultured clinical specimens. Sex. Transm. Infect. 1, 51\u201355 (2010).","journal-title":"Sex. Transm. Infect."},{"key":"BFnrmicro3217_CR48","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1128\/JCM.01909-06","volume":"45","author":"MJ Siedner","year":"2007","unstructured":"Siedner, M. J. et al. Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples. J. Clin. Microbiol. 45, 1250\u20131254 (2007).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrmicro3217_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/AAC.45.1.117-123.2001","volume":"45","author":"X Su","year":"2001","unstructured":"Su, X. & Lind, I. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998. Antimicrob. Agents Chemother. 45, 117\u2013123 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrmicro3217_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijantimicag.2013.02.026","volume":"42","author":"MP Magooa","year":"2013","unstructured":"Magooa, M. P., M\u00fcller, E. E., Gumede, L. & Lewis, D. A. Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay. Int. J. Antimicrob. Agents 42, 63\u201367 (2013).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFnrmicro3217_CR51","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1128\/CMR.14.4.836-871.2001","volume":"14","author":"AC Fluit","year":"2001","unstructured":"Fluit, A. C., Visser, M. R. & Schmitz, F.-J. Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 14, 836\u2013871 (2001).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFnrmicro3217_CR52","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1128\/JCM.02024-10","volume":"2","author":"N Goire","year":"2011","unstructured":"Goire, N. et al. Enhancing gonococcal antimicrobial resistance surveillance: a real-time PCR assay for detection of penicillinase-producing Neisseria gonorrhoeae by use of noncultured clinical samples. J. Clin. Microbiol. 2, 513\u2013518 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrmicro3217_CR53","doi-asserted-by":"publisher","unstructured":"Speers, D. J,, Fisk, R. E, Goire, N, & Mak, D. B. Non-culture Neisseria gonorrhoeae molecular penicillinase production surveillance demonstrates the long-term success of empirical dual therapy and informs gonorrhoea management guidelines in a highly endemic setting. J. Antimicrob. Chemother. http:\/\/dx.doi.org\/10.1093\/jac\/dkt501 ; (2013).","DOI":"10.1093\/jac\/dkt501"},{"key":"BFnrmicro3217_CR54","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/jac\/dkr549","volume":"67","author":"N Goire","year":"2012","unstructured":"Goire, N. et al. Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain. J. Antimicrob. Chemother. 67, 902\u2013905 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrmicro3217_CR55","doi-asserted-by":"publisher","first-page":"20444","DOI":"10.2807\/1560-7917.ES2013.18.14.20444","volume":"18","author":"N Goire","year":"2013","unstructured":"Goire, N. et al. Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain. Euro Surveill. 18, 20444 (2013).","journal-title":"Euro Surveill."},{"key":"BFnrmicro3217_CR56","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/1471-2334-13-570","volume":"13","author":"S Gose","year":"2013","unstructured":"Gose, S. et al. Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA. BMC Infect. Dis. 13, 570 (2013).","journal-title":"BMC Infect. Dis."},{"key":"BFnrmicro3217_CR57","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/cid\/cir929","volume":"54","author":"AR Katz","year":"2012","unstructured":"Katz, A. R. et al. Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. Clin. Infect. Dis. 54, 841\u2013843 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrmicro3217_CR58","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jmoldx.2012.08.005","volume":"15","author":"S Balashov","year":"2012","unstructured":"Balashov, S., Mordechai, E., Adelson, M. E. & Gygax, S. E. Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples. J. Mol. Diagn. 15, 116\u2013129 (2012).","journal-title":"J. Mol. Diagn."},{"key":"BFnrmicro3217_CR59","doi-asserted-by":"publisher","unstructured":"Grad, Y. H. et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect. Dis. http:dx.doi.org\/10.1016\/S1473-3099(13)70693-5 (2014).","DOI":"10.1016\/S1473-3099(13)70693-5"},{"key":"BFnrmicro3217_CR60","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1128\/JCM.00806-13","volume":"51","author":"SN Tabrizi","year":"2013","unstructured":"Tabrizi, S. N. et al. Analytical evaluation of GeneXpert CT\/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. J. Clin. Microbiol. 51, 1945\u20131947 (2013).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrmicro3217_CR61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/POC.0b013e318222e184","volume":"11","author":"G Spizz","year":"2012","unstructured":"Spizz, G. et al. Rheonix CARD\u00ae technology: an innovative and fully automated molecular diagnostic device. Point Care 11, 42\u201351 (2012).","journal-title":"Point Care"},{"key":"BFnrmicro3217_CR62","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2011.08.021","volume":"71","author":"V Doseeva","year":"2011","unstructured":"Doseeva, V. et al. Multiplex isothermal helicase-dependent amplification assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. Diagn. Microbiol. Infect. Dis. 71, 354\u2013365 (2011).","journal-title":"Diagn. Microbiol. Infect. Dis."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrmicro3217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro3217","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro3217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:38:06Z","timestamp":1684471086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrmicro3217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,10]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["BFnrmicro3217"],"URL":"https:\/\/doi.org\/10.1038\/nrmicro3217","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,10]]}}}